Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.7 (
DNA polymerase
)
17,007
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Seven temperature-sensitive mutants of vaccinia virus have been isolated after preselection for virus resistant to phosphonoacetic acid (PAA). In all seven mutants, the PAA-resistant (PAAr) and ts lesions represent separate mutations. In one mutant,
NG26
, the PAAr (NG26-PAAr) and ts (NG26-ts) mutations are very closely linked. Both
NG26
-ts and
NG26
-PAAr map in the HindIII E DNA fragment.
NG26
has a DNA-negative phenotype at 40 degrees.
NG26
-ts is in the same complementation group as ts42, another DNA-negative mutant which maps in the HindIII E DNA fragment (R. C. Condit, A. Motyczka, and G. Spizz, Virology 128, 000-000, 1983). The order of the mutations is (NG26-ts)-(NG26-PAAr)-ts42. The virus-coded
DNA polymerase
has been partially purified from wt- and
NG26
-infected cells. The
DNA polymerase
encoded by
NG26
is temperature sensitive and PAA resistant in vitro as compared to the wt enzyme.
...
PMID:Selection for temperature-sensitive mutations in specific vaccinia virus genes: isolation and characterization of a virus mutant which encodes a phosphonoacetic acid-resistant, temperature-sensitive DNA polymerase. 661 92